5:02 pm Sinovac Biotech: EV71 vaccine Phase 3 clinical trial results published in NEJM; Study shows vaccine provides protection against EV71-associated hand, foot and mouth disease in infants and young children – HedgeChatter

5:02 pm Sinovac Biotech: EV71 vaccine Phase 3 clinical trial results published in NEJM; Study shows vaccine provides protection against EV71-associated hand, foot and mouth disease in infants and young children

26 Feb

5:02 pm Sinovac Biotech: EV71 vaccine Phase 3 clinical trial results published in NEJM; Study shows vaccine provides protection against EV71-associated hand, foot and mouth disease in infants and young children

Bystocknews stock, SVA Comments Off

View todays social media effects on SVA

View the latest stocks trending across Twitter. Click to view dashboard

See who Sinovac is hiring next, click here to view

Author